11/21
08:43 am
mplt
Rating for MPLT
Medium
Report
Rating for MPLT
11/21
08:43 am
mplt
Rating for MPLT
Medium
Report
Rating for MPLT
11/21
08:05 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $30.00 price target on the stock.
Low
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $30.00 price target on the stock.
11/21
07:34 am
mplt
MapLight Therapeutics initiated with an Outperform at Leerink
Low
Report
MapLight Therapeutics initiated with an Outperform at Leerink
11/21
07:21 am
mplt
Rating for MPLT
Medium
Report
Rating for MPLT
11/21
07:19 am
mplt
Rating for MPLT
Medium
Report
Rating for MPLT
11/21
07:16 am
mplt
Rating for MPLT
Medium
Report
Rating for MPLT
11/21
07:16 am
mplt
Rating for MPLT
Medium
Report
Rating for MPLT
11/21
06:04 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
11/21
06:04 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
11/21
05:07 am
mplt
MapLight Therapeutics initiated with a Buy at Jefferies
Medium
Report
MapLight Therapeutics initiated with a Buy at Jefferies
11/21
05:07 am
mplt
MapLight Therapeutics initiated with a Buy at Jefferies
Medium
Report
MapLight Therapeutics initiated with a Buy at Jefferies
11/21
05:05 am
mplt
MapLight Therapeutics initiated with a Buy at Stifel
Medium
Report
MapLight Therapeutics initiated with a Buy at Stifel
11/21
05:04 am
mplt
MapLight Therapeutics initiated with an Overweight at Morgan Stanley
Medium
Report
MapLight Therapeutics initiated with an Overweight at Morgan Stanley
11/21
05:04 am
mplt
MapLight Therapeutics initiated with an Overweight at Morgan Stanley
Medium
Report
MapLight Therapeutics initiated with an Overweight at Morgan Stanley